Characterized by tissue destruction, fibrosis, and immune dysregulation.
Key mediators include cytokines (IL-1, IL-6, TNF-α), chemokines, reactive oxygen species (ROS), matrix metalloproteinases (MMPs), and growth factors (VEGF).
Cytokines
Cytokines are immune mediators that stimulate or inhibit immune cell differentiation, proliferation, or activity.
Chemokines guide immune cells to infection sites.
Extravasation
Cytokines (histamine) promote adhesion molecule expression on the endothelium and vascular permeabilization, facilitating white blood cell extravasation.
Organs of the Immune System
Thymus: T-cell maturation.
Tonsils: Trap pathogens.
Spleen: Filters blood and activates immune cells.
Lymph nodes: Filter lymph and activate lymphocytes.
Bone marrow: Produces immune cells.
Types of Immunity
Innate Immunity: Rapid, generalized response using physical barriers, cytokine production and complement activation; lacks memory.
Adaptive Immunity: Slower, specific response involving T cells, B cells, and NKT cells; forms long-lasting memory.
Humoral Immunity: Uses antibodies to target extracellular antigens.
Cell-Mediated Immunity: T cells, macrophages, or NK cells destroy infected cells.
Monoclonal Antibodies (mAbs)
mAbs bind antigens with high specificity due to their unique antigen-binding sites.
Used in cancer therapy, autoimmune diseases, allergic conditions, infectious diseases, and more.
The global market for monoclonal antibodies is significant and growing.
Treatment of Inflammatory Disorders
Non-steroidal anti-inflammatory drugs (NSAIDs).
Glucocorticoids.
Immunosuppressants.
Monoclonal antibodies.
Summary
Inflammation results from tissue injury or infection and involves both innate and adaptive immune responses.
Intervention is needed when inflammation is unresolved (chronic).
Conditions are treated with drugs like NSAIDs, steroids, and immunosuppressants.
Development & use of mAbs is increasing, but cost & toxicity are issues.